Registration is now open for the Pacific Southwest ATTC and CA Hub and Spoke System Presents: Understanding Buprenorphine Formulations and Clinical Guidelines for Use. This web training is co-sponsored by UCLA Integrated Substance Abuse Programs, the Pacific Addiction Technology Transfer Center, California Department of Health Care Services, and the California Hub and Spoke System. Free CE credits available.
This 90-minute web training will provide an overview of the various formulations of buprenorphine (including tablet, film, implantable, and injectable) for the treatment of opioid use disorder. Larissa Mooney, MD, and David Grelotti, MD, will discuss the differences in the delivery of each formulation as well as provide their clinical practice experiences with each formulation. A consumer will discuss finding the right formulation for his treatment.
Presenters: Larissa Mooney, MD, Associate Clinical Professor of Psychiatry at UCLA and Director of the UCLA Addiction Medicine Clinic
David Grelotti, MD, Associate Professor of Psychiatry UCSD and the Director of Mental Health and Substance Use Treatment Services at UCSD’s Owen Clinic
Date: Monday, March 16th, 2020
Time: 1:00 – 2:30 PM PDT
Register here: https://uclahs.zoom.us/webinar/register/WN_XXVizgspT5ukU_naKed_eQ
